176 related articles for article (PubMed ID: 30052999)
21. m
Xia Z; Xu J; Lu E; He W; Deng S; Gong AY; Strass-Soukup J; Martins GA; Lu G; Chen XM
Front Immunol; 2021; 12():705232. PubMed ID: 34295340
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of apoptosis in Cryptosporidium parvum-infected intestinal epithelial cells is dependent on survivin.
Liu J; Enomoto S; Lancto CA; Abrahamsen MS; Rutherford MS
Infect Immun; 2008 Aug; 76(8):3784-92. PubMed ID: 18519556
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of attachment and internalization of Cryptosporidium parvum to biliary and intestinal epithelial cells.
Chen XM; LaRusso NF
Gastroenterology; 2000 Feb; 118(2):368-79. PubMed ID: 10648465
[TBL] [Abstract][Full Text] [Related]
24. Cryptosporidium parvum infection attenuates the ex vivo propagation of murine intestinal enteroids.
Zhang XT; Gong AY; Wang Y; Chen X; Lim SS; Dolata CE; Chen XM
Physiol Rep; 2016 Dec; 4(24):. PubMed ID: 28039407
[TBL] [Abstract][Full Text] [Related]
25. Cryptosporidium parvum disrupts intestinal epithelial barrier in neonatal mice through downregulation of cell junction molecules.
Luo C; Xu Y; Zhang J; Tian Q; Guo Y; Li N; Feng Y; Xu R; Xiao L
PLoS Negl Trop Dis; 2024 May; 18(5):e0012212. PubMed ID: 38787872
[TBL] [Abstract][Full Text] [Related]
26. SHP-2 Mediates Cryptosporidium parvum Infectivity in Human Intestinal Epithelial Cells.
Varughese EA; Kasper S; Anneken EM; Yadav JS
PLoS One; 2015; 10(11):e0142219. PubMed ID: 26556238
[TBL] [Abstract][Full Text] [Related]
27. Cryptosporidium parvum infects human cholangiocytes via sphingolipid-enriched membrane microdomains.
Nelson JB; O'Hara SP; Small AJ; Tietz PS; Choudhury AK; Pagano RE; Chen XM; LaRusso NF
Cell Microbiol; 2006 Dec; 8(12):1932-45. PubMed ID: 16848787
[TBL] [Abstract][Full Text] [Related]
28. Bovine TLR2 and TLR4 mediate Cryptosporidium parvum recognition in bovine intestinal epithelial cells.
Yang Z; Fu Y; Gong P; Zheng J; Liu L; Yu Y; Li J; Li H; Yang J; Zhang X
Microb Pathog; 2015 Aug; 85():29-34. PubMed ID: 26048276
[TBL] [Abstract][Full Text] [Related]
29. In Vitro Culture of Cryptosporidium parvum Using Stem Cell-Derived Intestinal Epithelial Monolayers.
Wilke G; Wang Y; Ravindran S; Stappenbeck T; Witola WH; Sibley LD
Methods Mol Biol; 2020; 2052():351-372. PubMed ID: 31452172
[TBL] [Abstract][Full Text] [Related]
30. Interferon-λ3 Promotes Epithelial Defense and Barrier Function Against Cryptosporidium parvum Infection.
Ferguson SH; Foster DM; Sherry B; Magness ST; Nielsen DM; Gookin JL
Cell Mol Gastroenterol Hepatol; 2019; 8(1):1-20. PubMed ID: 30849550
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA expression profile of HCT-8 cells in the early phase of Cryptosporidium parvum infection.
Wang C; Liu L; Zhu H; Zhang L; Wang R; Zhang Z; Huang J; Zhang S; Jian F; Ning C; Zhang L
BMC Genomics; 2019 Jan; 20(1):37. PubMed ID: 30642246
[TBL] [Abstract][Full Text] [Related]
32. Cryptosporidium parvum activates nuclear factor kappaB in biliary epithelia preventing epithelial cell apoptosis.
Chen XM; Levine SA; Splinter PL; Tietz PS; Ganong AL; Jobin C; Gores GJ; Paya CV; LaRusso NF
Gastroenterology; 2001 Jun; 120(7):1774-83. PubMed ID: 11375958
[TBL] [Abstract][Full Text] [Related]
33. Host intestinal epithelial response to Cryptosporidium parvum.
Deng M; Rutherford MS; Abrahamsen MS
Adv Drug Deliv Rev; 2004 Apr; 56(6):869-84. PubMed ID: 15063595
[TBL] [Abstract][Full Text] [Related]
34. The Cryptosporidium parvum transcriptome during in vitro development.
Mauzy MJ; Enomoto S; Lancto CA; Abrahamsen MS; Rutherford MS
PLoS One; 2012; 7(3):e31715. PubMed ID: 22438867
[TBL] [Abstract][Full Text] [Related]
35. Cryptosporidium parvum invasion of biliary epithelia requires host cell tyrosine phosphorylation of cortactin via c-Src.
Chen XM; Huang BQ; Splinter PL; Cao H; Zhu G; McNiven MA; LaRusso NF
Gastroenterology; 2003 Jul; 125(1):216-28. PubMed ID: 12851885
[TBL] [Abstract][Full Text] [Related]
36. Human primary intestinal epithelial cells as an improved in vitro model for Cryptosporidium parvum infection.
Castellanos-Gonzalez A; Cabada MM; Nichols J; Gomez G; White AC
Infect Immun; 2013 Jun; 81(6):1996-2001. PubMed ID: 23509153
[TBL] [Abstract][Full Text] [Related]
37. Cryptosporidium parvum increases intestinal permeability through interaction with epithelial cells and IL-1β and TNFα released by inflammatory monocytes.
de Sablet T; Potiron L; Marquis M; Bussière FI; Lacroix-Lamandé S; Laurent F
Cell Microbiol; 2016 Dec; 18(12):1871-1880. PubMed ID: 27324279
[TBL] [Abstract][Full Text] [Related]
38. Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines.
Laurent F; Eckmann L; Savidge TC; Morgan G; Theodos C; Naciri M; Kagnoff MF
Infect Immun; 1997 Dec; 65(12):5067-73. PubMed ID: 9393797
[TBL] [Abstract][Full Text] [Related]
39. Biphasic modulation of apoptotic pathways in Cryptosporidium parvum-infected human intestinal epithelial cells.
Liu J; Deng M; Lancto CA; Abrahamsen MS; Rutherford MS; Enomoto S
Infect Immun; 2009 Feb; 77(2):837-49. PubMed ID: 19075026
[TBL] [Abstract][Full Text] [Related]
40. Cryptosporidium parvum regulation of human epithelial cell gene expression.
Deng M; Lancto CA; Abrahamsen MS
Int J Parasitol; 2004 Jan; 34(1):73-82. PubMed ID: 14711592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
